We bring you the latest news from the healthcare about the health care in the United Kingdom. Do your have news for us? Contact the editor. Watch also this special movie.

vrijdag 5 januari 2018

Journal of Antibiotics - Table of Contents alert Volume 71 Issue 1

If you are unable to see the message below, click here to view.
The Journal of Antibiotics
 
TABLE OF CONTENTS

Special Issue Dedicated to Hamao Umezawa: In memory of Professor Umezawa on the occasion of the 60th anniversary of global kanamycin marketing

The January issue of The Journal of Antibiotics is dedicated to Professor Hamao Umezawa on the occasion of the 60th anniversary of global kanamycin marketing. He was a board member of The Journal of Antibiotics from its first issue in 1947 until his death in 1986 and contributed to it gaining its reputation as a leading international journal.
We would like to thank his friends and followers who contributed to this special issue, as well as Managing Editor Dr. Yoshikazu Takahashi and Dr. Manabu Kawada for planning and coordinating this issue.

The Journal of Antibiotics

Please see articles marked  

 

Volume 71, Issue 1 (January 2018)

In this issue
Editorials
Review Articles
Original Articles
Notes
Also new
AOP
 
Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Subscribe

Editorials

Preface: special issue Hamao Umezawa (1914–1986)

Kuniaki Tatsuta, Yoshikazu Takahashi& Manabu Kawada

The Journal of Antibiotics 2018 71: 1; January 05, 2018; 10.1038/ja.2017.136

 

Abstract | Full Text

Memory of Professor Hamao Umezawa

Masakatsu Shibasaki & Katsuhisa Yamazaki

The Journal of Antibiotics 2018 71: 2 - 3; January 05, 2018; 10.1038/ja.2017.137

 

Abstract | Full Text

Review Articles

Destination of aminoglycoside antibiotics in the 'post-antibiotic era'

Yoshiaki Takahashi & Masayuki Igarashi

The Journal of Antibiotics 2017 71: 4 - 14; October 25, 2017; 10.1038/ja.2017.117

 

Abstract | Full Text

New antituberculous drugs derived from natural products: current perspectives and issues in antituberculous drug development

Masayuki Igarashi, Yoshimasa Ishizaki& Yoshiaki Takahashi

The Journal of Antibiotics 2017 71: 15 - 25; November 01, 2017; 10.1038/ja.2017.126

 

Abstract | Full Text

Our microbes not only produce antibiotics, they also overproduce amino acids

Sergio Sanchez, Romina Rodríguez-Sanoja, Allison Ramos& Arnold L Demain

The Journal of Antibiotics 2017 71: 26 - 36; November 01, 2017; 10.1038/ja.2017.142

 

Abstract | Full Text

Professor Hamao Umezawa opened up a new road for the development of molecularly targeted therapeutic drugs for cancers

Masaya Imoto

The Journal of Antibiotics 2017 71: 37 - 38; November 01, 2017; 10.1038/ja.2017.139

 

Abstract | Full Text

Novel approaches for identification of anti-tumor drugs and new bioactive compounds

Manabu Kawada, Sonoko Atsumi, Shun-ichi Wada& Shuichi Sakamoto

The Journal of Antibiotics 2017 71: 39 - 44; August 30, 2017; 10.1038/ja.2017.97

 

Abstract | Full Text

Current landscape and future prospects of antiviral drugs derived from microbial products

Naoki Takizawa & Manabu Yamasaki

The Journal of Antibiotics 2017 71: 45 - 52; October 11, 2017; 10.1038/ja.2017.115

 

Abstract | Full Text

Synthetic studies of viridiofungins, broad-spectrum antifungal agents and serine palmitoyl transferase inhibitors

Naoya Kumagai & Masakatsu Shibasaki

The Journal of Antibiotics 2017 71: 53 - 59; September 27, 2017; 10.1038/ja.2017.110

 

Abstract | Full Text

Microbial metabolites and derivatives targeted at inflammation and bone diseases therapy: chemistry, biological activity and pharmacology

Hayamitsu Adachi, Koichi Nakae, Shuichi Sakamoto, Chisato Nosaka, Sonoko Atsumi et al.

The Journal of Antibiotics 2017 71: 60 - 71; November 01, 2017; 10.1038/ja.2017.138

 

Abstract | Full Text

Autophagy-regulating protease Atg4: structure, function, regulation and inhibition

Tatsuro Maruyama & Nobuo N Noda

The Journal of Antibiotics 2017 71: 72 - 78; September 13, 2017; 10.1038/ja.2017.104

 

Abstract | Full Text

Original Articles

In vivo efficacy of ß-lactam/tripropeptin C in a mouse septicemia model and the mechanism of reverse ß-lactam resistance in methicillin-resistant Staphylococcus aureus mediated by tripropeptin C

Hideki Hashizume, Yoshiaki Takahashi, Tohru Masuda, Shun-ichi Ohba, Tomokazu Ohishi et al.

The Journal of Antibiotics 2017 71: 79 - 85; July 26, 2017; 10.1038/ja.2017.88

 

Abstract | Full Text

Biological activity of intervenolin analogs with a phenyl substituent

Hikaru Abe, Manabu Kawada, Masayuki Igarashi, Shun-ichi Ohba, Chigusa Hayashi et al.

The Journal of Antibiotics 2017 71: 86 - 90; October 11, 2017; 10.1038/ja.2017.123

 

Abstract | Full Text

Quadoctomycin, a 48-membered macrolide antibiotic from Streptomyces sp. MM168-141F8

Ryuichi Sawa, Yumiko Kubota, Maya Umekita, Masaki Hatano, Chigusa Hayashi et al.

The Journal of Antibiotics 2017 71: 91 - 96; November 15, 2017; 10.1038/ja.2017.140

 

Abstract | Full Text

Engineered production and evaluation of 6'-deoxy-tallysomycin H-1 revealing new insights into the structure–activity relationship of the anticancer drug bleomycin

 

The Journal of Antibiotics 2017 71: 97 - 103; August 23, 2017; 10.1038/ja.2017.93

 

Abstract | Full Text

Synthesis and antibacterial activity of novel lincomycin derivatives. III. Optimization of a phenyl thiadiazole moiety

Ko Kumura, Yoshinari Wakiyama, Kazutaka Ueda, Eijiro Umemura, Takashi Watanabe et al.

The Journal of Antibiotics 2017 71: 104 - 112; July 05, 2017; 10.1038/ja.2017.59

 

Abstract | Full Text

Self-control of the PHO regulon: the PhoP-dependent protein PhoU controls negatively expression of genes of PHO regulon in Streptomyces coelicolor

Seomara Martín-Martín, Antonio Rodríguez-García, Fernando Santos-Beneit, Etelvina Franco-Domínguez, Alberto Sola-Landa et al.

The Journal of Antibiotics 2017 71: 113 - 122; November 01, 2017; 10.1038/ja.2017.130

 

Abstract | Full Text

Wakodecalines A and B, new decaline metabolites isolated from a fungus Pyrenochaetopsis sp. RK10-F058

Toshihiko Nogawa, Naoki Kato, Takeshi Shimizu, Akiko Okano, Yushi Futamura et al.

The Journal of Antibiotics 2017 71: 123 - 128; September 13, 2017; 10.1038/ja.2017.103

 

Abstract | Full Text

Valgamicin C, a novel cyclic depsipeptide containing the unusual amino acid cleonine, and related valgamicins A, T and V produced by Amycolatopsis sp. ML1-hF4

Hideki Hashizume, Kiyoko Iijima, Kazuma Yamashita, Tomoyuki Kimura, Shun-ichi Wada et al.

The Journal of Antibiotics 2017 71: 129 - 134; November 15, 2017; 10.1038/ja.2017.135

 

Abstract | Full Text

Notes

A guanine derivative as a new MEK inhibitor produced by Streptomyces sp. MK63-43F2

Masatomi Iijima, Yuji Kubota, Ryuichi Sawa, Yumiko Kubota, Masaki Hatano et al.

The Journal of Antibiotics 2017 71: 135 - 138; September 06, 2017; 10.1038/ja.2017.100

 

Abstract | Full Text

Rakicidin F, a new antibacterial cyclic depsipeptide from a marine sponge-derived Streptomyces sp.

Shigeru Kitani, Tatsuya Ueguchi, Yasuhiro Igarashi, Kantinan Leetanasaksakul, Arinthip Thamchaipenet et al.

The Journal of Antibiotics 2017 71: 139 - 141; August 02, 2017; 10.1038/ja.2017.92

 

Abstract | Full Text

Cellular uptake of modified aminoglycosides

Kaivin Hadidi, Ezequiel Wexselblatt, Jeffrey D Esko& Yitzhak Tor

The Journal of Antibiotics 2017 71: 142 - 145; November 01, 2017; 10.1038/ja.2017.131

 

Abstract | Full Text

Ascosteroside D, a new mitochondrial respiration inhibitor discovered by pesticidal screening using insect ADP/ATP carrier protein-expressing Saccharomyces cerevisiae

Yoshihiro Watanabe, Yukihiro Asami, Satomi Narusawa, Shohei Hashimoto, Masato Iwatsuki et al.

The Journal of Antibiotics 2017 71: 146 - 148; October 11, 2017; 10.1038/ja.2017.118

 

Abstract | Full Text

nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to The Journal of Antibiotics. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

Springer Nature